Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
“A significant effect was seen from the Optimer-delivered gene therapy… probability of these results is more than 99% due to the Optimer delivery of the gene therapy.”
Results look very promising and some really nice comparisons with other companies too. A great RNS showing potentially a very lucrative future. But they do need to bring in some revs pretty soon to extend the current runway, so currently not without risk.
Angel Investor. .
Good to see someone, with deep pockets, mopping up shares at these low SP levels bit by bit; and see the stake rising slowly upwards.
I am googling but who is Saren Chari?
Reflection of faith and commitment to the company....some different to many other aim companies.....
Ups his stake to 4.39%
...especially quantified and the sp may hold, but unfortunately, at the moment it can be manipulated +/_ 10%
Exposure to new clients is always beneficial, offering endless opportunities. However, it's crucial not to overlook the significant risk of rejection with transplants.
Therefore, any strategies to mitigate this risk are highly desirable; will be used.
Good rns this could go places only thing is fee for service..we needed figures 😔 for the market and none given .so we don't know as yet how much.But good to see a positive RNS
...buying....
Until we get some positive news I fear cash burn will take over ..60% down on a large holding to be honest getting fed up now as hype is not producing into cash and anything else..the market here is not happy..so come on guys let's turn things around or I won't be and my sell off at a loss will really show
Well, this baby had a Mkt cap of 80mln some months back, on the basis of its potential growth; that growth stuttered due to delays in revenues' coming in from expected licensing deals (Unilever, pharma top 5, 10, and 15), but we know now that we will have news on at least 3 of these projects (Unilever, top5 and 15) sometime this year; possibly on LFTs with Neuro-Bio too. If anyone thinks that a 2mln Mkt cap is a "risky" situation Vs the upside, they can sell out (and buy in later, if it becomes cheaper).
GLA, DYOR
"Most traders enter and exit with profits" Utter Twaddle!
Most 'traders' lose money trying to dip in and out!
He's running around shouting this nonsense.
Or you can buy really cheap stocks (your CORE holdings), with excellent potential, and gradually build your stake in them at low prices. Sometimes the baby grows up, from an ugly duckling, to be really beautiful.
Most traders enter and exit with profits, and if you stay too long, you'll be left holding the baby.
Never become attached to any share on AIM.
That's over 1.6% of stock; probably explains the 20% rise last Friday.
It's important to reiterate that Dr Tolley mentioned, after a specific question during the interims' presentation, that licensing income could flow within a couple of years (from UNILEVER) however, whilst getting there, APTA would still receive a lot of fees-for-services as a lot of testing needs to be done by then.
UNILEVER competitors will also be alerted to what APTA is doing for UNILEVER, so maybe new contracts will come from other players.
FORGET that no rns it was from the other day SORRY
Major investor has added another few million. Follow the money
Popped in, crapped the sh*t up, and then bagged off. Some others took his/her place.
Good luck ppl!
Srange they lost nearly 300 the bid has just moved up
....a rarity on aim.....Good luck all.
This will also raise APTA's profile in the CITY, and make people realise that these short-term hiccups re cashflow are temporary and a great BUYING opportunity!